Arrowstreet Capital Limited Partnership Trims Position in Alnylam Pharmaceuticals, Inc. $ALNY
MarketBeat
Arrowstreet Capital Limited Partnership trimmed its holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 16.9% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 1,127,162 shares of the biopharmaceutical company's stock after selling 228,
NASDAQ:ALNY